8-KThe WireStrategic
Exit / Disposal Costs · Reg FD Disclosure
Filed Dec 19, 2023 · 2y ago · Accession 0001558370-23-019911
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Aclaris Therapeutics, Inc.
- Ticker
- ACRS
- CIK
- 1557746
- Form type
- 8-K
- Filing date
- Dec 19, 2023
- Report date
- Dec 19, 2023
- Document
- acrs-20231219x8k.htm
- Size
- 205 KB